These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 11334962)
1. Development of an ELISA to measure soluble CD163 in biological fluids. Sulahian TH; Hintz KA; Wardwell K; Guyre PM J Immunol Methods; 2001 Jun; 252(1-2):25-31. PubMed ID: 11334962 [TBL] [Abstract][Full Text] [Related]
2. Characterization of an enzyme-linked immunosorbent assay for soluble CD163. Møller HJ; Hald K; Moestrup SK Scand J Clin Lab Invest; 2002; 62(4):293-9. PubMed ID: 12476928 [TBL] [Abstract][Full Text] [Related]
3. Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levels. Davis BH; Zarev PV Cytometry B Clin Cytom; 2005 Jan; 63(1):16-22. PubMed ID: 15624200 [TBL] [Abstract][Full Text] [Related]
4. Comparative assessment of the recognition of domain-specific CD163 monoclonal antibodies in human monocytes explains wide discrepancy in reported levels of cellular surface CD163 expression. Maniecki MB; Etzerodt A; Moestrup SK; Møller HJ; Graversen JH Immunobiology; 2011 Aug; 216(8):882-90. PubMed ID: 21458881 [TBL] [Abstract][Full Text] [Related]
5. CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response. Moestrup SK; Møller HJ Ann Med; 2004; 36(5):347-54. PubMed ID: 15478309 [TBL] [Abstract][Full Text] [Related]
6. Proteolytic shedding of the macrophage scavenger receptor CD163 in multiple sclerosis. Fabriek BO; Møller HJ; Vloet RP; van Winsen LM; Hanemaaijer R; Teunissen CE; Uitdehaag BM; van den Berg TK; Dijkstra CD J Neuroimmunol; 2007 Jul; 187(1-2):179-86. PubMed ID: 17537523 [TBL] [Abstract][Full Text] [Related]
8. Elevated levels of soluble CD163 in sera and fluids from rheumatoid arthritis patients and inhibition of the shedding of CD163 by TIMP-3. Matsushita N; Kashiwagi M; Wait R; Nagayoshi R; Nakamura M; Matsuda T; Hogger P; Guyre PM; Nagase H; Matsuyama T Clin Exp Immunol; 2002 Oct; 130(1):156-61. PubMed ID: 12296867 [TBL] [Abstract][Full Text] [Related]
10. Development and application of a porcine specific ELISA for the quantification of soluble CD163. Pasternak JA; MacPhee DJ; Harding JCS Vet Immunol Immunopathol; 2019 Apr; 210():60-67. PubMed ID: 30947982 [TBL] [Abstract][Full Text] [Related]
11. Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy. Van Gorp H; Delputte PL; Nauwynck HJ Mol Immunol; 2010 Apr; 47(7-8):1650-60. PubMed ID: 20299103 [TBL] [Abstract][Full Text] [Related]
12. Differential expression of monocyte CD163 in single- and dual-asthmatic responders during allergen-induced bronchoconstriction. Kowal K; Møller HJ; Dubuske LM; Moestrup SK; Bodzenta-Lukaszyk A Clin Exp Allergy; 2006 Dec; 36(12):1584-91. PubMed ID: 17177682 [TBL] [Abstract][Full Text] [Related]
14. Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoid-inducible member of the scavenger receptor cysteine-rich family (CD163). Högger P; Dreier J; Droste A; Buck F; Sorg C J Immunol; 1998 Aug; 161(4):1883-90. PubMed ID: 9712057 [TBL] [Abstract][Full Text] [Related]
16. Monocyte CD163 is altered in association with diabetic complications: possible protective role. Min D; Brooks B; Wong J; Aamidor S; Seehoo R; Sutanto S; Harrisberg B; Yue DK; Twigg SM; McLennan SV J Leukoc Biol; 2016 Dec; 100(6):1375-1383. PubMed ID: 27354410 [TBL] [Abstract][Full Text] [Related]
17. The macrophage scavenger receptor CD163. Fabriek BO; Dijkstra CD; van den Berg TK Immunobiology; 2005; 210(2-4):153-60. PubMed ID: 16164022 [TBL] [Abstract][Full Text] [Related]
18. Generation and validation of novel anti-bovine CD163 monoclonal antibodies ABM-1A9 and ABM-2D6. Shimamoto Y; Nio-Kobayashi J; Watarai H; Nagano M; Saito N; Takahashi E; Higuchi H; Kobayashi A; Kimura T; Kitamura H Vet Immunol Immunopathol; 2018 Apr; 198():6-13. PubMed ID: 29571519 [TBL] [Abstract][Full Text] [Related]
19. Phenotypic commitment of monocytes towards a protective hemoglobin scavenging phenotype (CD14(pos)CD163(high)HLA-DR(low))following cardiopulmonary bypass. Quimby KR; Greenidge A; Harris A; Landis RC Cytometry B Clin Cytom; 2010 Sep; 78(5):357-60. PubMed ID: 20533393 [TBL] [Abstract][Full Text] [Related]
20. Shedding of CD163, a novel regulatory mechanism for a member of the scavenger receptor cysteine-rich family. Droste A; Sorg C; Högger P Biochem Biophys Res Commun; 1999 Mar; 256(1):110-3. PubMed ID: 10066432 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]